Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Cornea. 2020 Mar;39(3):311–315. doi: 10.1097/ICO.0000000000002171

Table 2:

Demographics and co-morbidities by EMS marker status

EMS positive EMS negative P value
Demographics
 Age, mean (SD) years 54.1 (11.8) 59.6 (15.7) 0.29
 Gender, male % (n) 62.5% (20) 75.0% (9) 0.50
 Race, White % (n) 62.5% (20) 41.7% (5) 0.11
 Ethnicity, Hispanic or Latino % (n) 40.6% (13) 8.3% (1) 0.07
Co-morbidities, % (n)
 Hypertension 21.9% (7) 50.0% (6) 0.07
 Diabetes 9.4% (3) 25.0% (3) 0.32
 COPD or asthma 15.6% (5) 0.0% (0) 0.30
 Depression 62.5% (20) 50.0% (6) 0.45
 Systemic autoimmune disease 15.6% (5) 0.0% (0) 0.3
Medications, % (n)
 Anti-hypertensives 21.9% (7) 41.7% (5) 0.26
 NSAIDs 40.6% (13) 50.0% (6) 0.74
 Anti-histamines 50.0% (16) 41.7% (5) 0.74
 Anti-depressants 53.1% (17) 41.7% (5) 0.50
 Analgesics 53.1% (15) 50.0% (6) 0.85

EMS=Early Markers of Sjögrens; SD=standard deviation; COPD=chronic obstructive pulmonary disease; NSAIDs=Non-steroidal anti-inflammatory drugs